| 标题 |
Aumolertinib plus chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 19 deletion or exon 21 L858R: a phase II trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Oncologist 作者:Yanwei Li; Chenguang Li; Xiaoliang Zhao; Yong Li; Feng He; Zhanyu Pan 出版日期:2025-03-15 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)